Loading clinical trials...
Loading clinical trials...
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm.
To determine if prophylactic administration of amiodarone for 72 hours in critically ill patients admitted after an OHCA with shockable rhythm, with a confirmed or a presumed cardiac cause, decreases the incidence of a composite endpoint of 30-day (starting from inclusion) all-cause mortality and/or severe in-hospital ventricular arrhythmia recurrence (ventricular fibrillation and/or ventricular tachycardia requiring intervention including re-arrest)
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Chu Amiens
Amiens, France
Chu Angers
Angers, France
CH annecy genevois
Annecy, France
Ch Argenteuil
Argenteuil, France
CH Mondor
Aurillac, France
CHU Brest
Brest, France
CH Brive
Brive-la-Gaillarde, France
Chu Caen
Caen, France
Chi Nord Ardennes
Charleville-Mézières, France
CHSF
Corbeil-Essonnes, France
Start Date
November 6, 2025
Primary Completion Date
January 15, 2027
Completion Date
March 15, 2027
Last Updated
December 23, 2025
674
ESTIMATED participants
Amiodarone
DRUG
Lead Sponsor
Versailles Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions